AbbVie Operating Cash Flow decreased by 26.6% to $3.83B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 134.2%, from $1.64B to $3.83B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -4.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Consistently high operating cash flow indicates a healthy, self-sustaining business capable of funding its own growth and returning capital to shareholders.
Net cash from operating activities measures the total amount of cash generated by a company's core business operations....
Investors often compare this to capital expenditures to calculate Free Cash Flow, a primary valuation metric for mature tech giants.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.89B | $7.94B | $5.08B | $4.91B | $5.01B | $7.60B | $7.43B | $4.19B | $6.32B | $7.57B | $4.75B | $4.04B | $2.27B | $5.45B | $7.05B | $1.64B | $5.15B | $7.02B | $5.22B | $3.83B |
| QoQ Change | — | +62.3% | -36.0% | -3.3% | +2.0% | +51.9% | -2.3% | -43.6% | +50.7% | +19.9% | -37.2% | -15.0% | -43.8% | +139.9% | +29.4% | -76.8% | +215.2% | +36.3% | -25.7% | -26.6% |
| YoY Change | — | — | — | — | +2.4% | -4.2% | +46.4% | -14.6% | +26.3% | -0.4% | -36.0% | -3.6% | -64.1% | -28.1% | +48.3% | -59.5% | +126.9% | +29.0% | -26.0% | +134.2% |